Top Avana

Developed to target erectile dysfunction and intended to mitigate premature ejaculation by supporting sexual health.

Strengths: 30/50mg

Medicine details

Alternative names

Super Avana

Therapeutic class

Phosphodiesterase-5 Inhibitor

Pharmacological class

PDE5 Inhibitor

Precautions and warnings

monitor blood pressure; may impair ability to drive

Minor side effects

headache; flushing; nasal congestion

Moderate side effects

nausea; dizziness; dyspepsia

Dosage forms

Tablet

Administration route

Oral use

Prescription status

POM

Manufacturer

Menarini

Onset Time

15–30 minutes

Duration

4–6 hours

Storage instructions

Store below 30°C in a dry place.

Drug interactions

nitrates; alpha-blockers; alcohol

Age restrictions

Restricted to adults.

Pregnancy and breastfeeding

Not indicated for use in women.

Contraindications

concurrent use of nitrates; severe heart disease; recent stroke; severe hepatic impairment

Serious side effects

priapism — requires immediate medical attention; sudden vision loss — requires immediate medical attention

Patient summary

Developed to target erectile dysfunction and intended to mitigate premature ejaculation by supporting sexual health.

Mechanism of action

Avanafil increases blood flow to the penis during sexual stimulation by inhibiting the PDE5 enzyme, while dapoxetine increases serotonin activity in the nervous system to delay ejaculation.

Top Avana

Developed to target erectile dysfunction and intended to mitigate premature ejaculation by supporting sexual health.

Editorial Notes

  • Active ingredient(s): Avanafil, Dapoxetine
  • Listed indication(s): Erectile Dysfunction, Premature Ejaculation

Available option

  • 20 tablets - 30/50 mg976-30-50-mg-15490